‹ LGND latest research

LGND (Ligand Pharmaceuticals Incorpor): every AI call and what happened next

TradeFlare's AI research teams analysed LGND on 8 market nights between May 11, 2026 and August 14, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

8 calls 6 BUY · 2 HOLD · 0 SELL BUY calls up after 20 trading days: 2 of 6
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
August 14, 2026 BUY $288.82 $310.50 / $256.50 -2.8% -4.7%
The technical setup suggests a potential short-term bounce, while the fundamental and sentiment tailwinds support a longer-term upward trend.
August 12, 2026 BUY $288.75 — / — -0.9% -1.4%
Continued strong revenue and earnings growth driven by the royalty-based business model.
August 3, 2026 BUY $287.54 $315.00 / $262.00 +1.2% -2.7%
The fundamental and sentiment tailwinds suggest a sustained upward move, while the technical setup offers an attractive entry point for a swing trade.
June 26, 2026 BUY $295.92 $325.60 / $266.40 +5.5% -2.0%
The 52-week breakout suggests immediate momentum, but the $300 psychological level and potential dilution risks warrant a medium-term outlook.
June 18, 2026 BUY $263.14 $297.37 / $236.83 +10.4% +7.0%
The stock is breaking out of a 52-week high with strong fundamental support, suggesting a medium-term trend continuation.
May 15, 2026 BUY $218.98 — / — +7.6% +18.8%
The current market conditions and technical indicators suggest a neutral stance, awaiting a clearer signal.
May 12, 2026 HOLD $220.48 — / — -6.4% +11.8%
Continued positive news flow regarding the XOMA Royalty acquisition and its integration.
May 11, 2026 HOLD $221.41 — / — -5.7% +10.3%
Successful integration and performance of the XOMA Royalty acquisition.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.